283 related articles for article (PubMed ID: 33293078)
1. A Systematic Review of the Evidence for the Decipher Genomic Classifier in Prostate Cancer.
Jairath NK; Dal Pra A; Vince R; Dess RT; Jackson WC; Tosoian JJ; McBride SM; Zhao SG; Berlin A; Mahal BA; Kishan AU; Den RB; Freedland SJ; Salami SS; Kaffenberger SD; Pollack A; Tran P; Mehra R; Morgan TM; Weiner AB; Mohamad O; Carroll PR; Cooperberg MR; Karnes RJ; Nguyen PL; Michalski JM; Tward JD; Feng FY; Schaeffer EM; Spratt DE
Eur Urol; 2021 Mar; 79(3):374-383. PubMed ID: 33293078
[TBL] [Abstract][Full Text] [Related]
2. A genomic classifier improves prediction of metastatic disease within 5 years after surgery in node-negative high-risk prostate cancer patients managed by radical prostatectomy without adjuvant therapy.
Klein EA; Yousefi K; Haddad Z; Choeurng V; Buerki C; Stephenson AJ; Li J; Kattan MW; Magi-Galluzzi C; Davicioni E
Eur Urol; 2015 Apr; 67(4):778-86. PubMed ID: 25466945
[TBL] [Abstract][Full Text] [Related]
3. Tissue-based Genomics Augments Post-prostatectomy Risk Stratification in a Natural History Cohort of Intermediate- and High-Risk Men.
Ross AE; Johnson MH; Yousefi K; Davicioni E; Netto GJ; Marchionni L; Fedor HL; Glavaris S; Choeurng V; Buerki C; Erho N; Lam LL; Humphreys EB; Faraj S; Bezerra SM; Han M; Partin AW; Trock BJ; Schaeffer EM
Eur Urol; 2016 Jan; 69(1):157-65. PubMed ID: 26058959
[TBL] [Abstract][Full Text] [Related]
4. Performance of a Prostate Cancer Genomic Classifier in Predicting Metastasis in Men with Prostate-specific Antigen Persistence Postprostatectomy.
Spratt DE; Dai DLY; Den RB; Troncoso P; Yousefi K; Ross AE; Schaeffer EM; Haddad Z; Davicioni E; Mehra R; Morgan TM; Rayford W; Abdollah F; Trabulsi E; Achim M; Tapia ELN; Guerrero M; Karnes RJ; Dicker AP; Hurwitz MA; Nguyen PL; Feng FFY; Freedland SJ; Davis JW
Eur Urol; 2018 Jul; 74(1):107-114. PubMed ID: 29233664
[TBL] [Abstract][Full Text] [Related]
5. Combined value of validated clinical and genomic risk stratification tools for predicting prostate cancer mortality in a high-risk prostatectomy cohort.
Cooperberg MR; Davicioni E; Crisan A; Jenkins RB; Ghadessi M; Karnes RJ
Eur Urol; 2015 Feb; 67(2):326-33. PubMed ID: 24998118
[TBL] [Abstract][Full Text] [Related]
6. Use of the Decipher genomic classifier among men with prostate cancer in the United States.
Zaorsky NG; Proudfoot JA; Jia AY; Zuhour R; Vince R; Liu Y; Zhao X; Hu J; Schussler NC; Stevens JL; Bentler S; Cress RD; Doherty JA; Durbin EB; Gershman S; Cheng I; Gonsalves L; Hernandez BY; Liu L; Morawski BM; Schymura M; Schwartz SM; Ward KC; Wiggins C; Wu XC; Shoag JE; Ponsky L; Dal Pra A; Schaeffer EM; Ross AE; Sun Y; Davicioni E; Petkov V; Spratt DE
JNCI Cancer Spectr; 2023 Aug; 7(5):. PubMed ID: 37525535
[TBL] [Abstract][Full Text] [Related]
7. Genomic Markers in Prostate Cancer Decision Making.
Cucchiara V; Cooperberg MR; Dall'Era M; Lin DW; Montorsi F; Schalken JA; Evans CP
Eur Urol; 2018 Apr; 73(4):572-582. PubMed ID: 29129398
[TBL] [Abstract][Full Text] [Related]
8. Genomic Classifier Performance in Intermediate-Risk Prostate Cancer: Results From NRG Oncology/RTOG 0126 Randomized Phase 3 Trial.
Spratt DE; Liu VYT; Michalski J; Davicioni E; Berlin A; Simko JP; Efstathiou JA; Tran PT; Sandler HM; Hall WA; Thompson DJS; Parliament MB; Dayes IS; Correa RJM; Robertson JM; Gore EM; Doncals DE; Vigneault E; Souhami L; Karrison TG; Feng FY
Int J Radiat Oncol Biol Phys; 2023 Oct; 117(2):370-377. PubMed ID: 37137444
[TBL] [Abstract][Full Text] [Related]
9. A Biopsy-based 17-gene Genomic Prostate Score as a Predictor of Metastases and Prostate Cancer Death in Surgically Treated Men with Clinically Localized Disease.
Van Den Eeden SK; Lu R; Zhang N; Quesenberry CP; Shan J; Han JS; Tsiatis AC; Leimpeter AD; Lawrence HJ; Febbo PG; Presti JC
Eur Urol; 2018 Jan; 73(1):129-138. PubMed ID: 28988753
[TBL] [Abstract][Full Text] [Related]
10. Individual Patient-Level Meta-Analysis of the Performance of the Decipher Genomic Classifier in High-Risk Men After Prostatectomy to Predict Development of Metastatic Disease.
Spratt DE; Yousefi K; Deheshi S; Ross AE; Den RB; Schaeffer EM; Trock BJ; Zhang J; Glass AG; Dicker AP; Abdollah F; Zhao SG; Lam LLC; du Plessis M; Choeurng V; Haddad Z; Buerki C; Davicioni E; Weinmann S; Freedland SJ; Klein EA; Karnes RJ; Feng FY
J Clin Oncol; 2017 Jun; 35(18):1991-1998. PubMed ID: 28358655
[TBL] [Abstract][Full Text] [Related]
11. Validation of a 22-Gene Genomic Classifier in Patients With Recurrent Prostate Cancer: An Ancillary Study of the NRG/RTOG 9601 Randomized Clinical Trial.
Feng FY; Huang HC; Spratt DE; Zhao SG; Sandler HM; Simko JP; Davicioni E; Nguyen PL; Pollack A; Efstathiou JA; Dicker AP; Todorovic T; Margrave J; Liu YS; Dabbas B; Thompson DJS; Das R; Dignam JJ; Sweeney C; Attard G; Bahary JP; Lukka HR; Hall WA; Pisansky TM; Shah AB; Pugh SL; Shipley WU; Tran PT
JAMA Oncol; 2021 Apr; 7(4):544-552. PubMed ID: 33570548
[TBL] [Abstract][Full Text] [Related]
12. Validation of the Decipher Test for Predicting Distant Metastatic Recurrence in Men with High-risk Nonmetastatic Prostate Cancer 10 Years After Surgery.
Van den Broeck T; Moris L; Gevaert T; Tosco L; Smeets E; Fishbane N; Liu Y; Helsen C; Margrave J; Buerki C; Davicioni E; Van Poppel H; Everaerts W; Weinmann S; Den R; Davis J; Schaeffer E; Karnes RJ; Claessens F; Joniau S
Eur Urol Oncol; 2019 Sep; 2(5):589-596. PubMed ID: 31411980
[TBL] [Abstract][Full Text] [Related]
13. Validation of a Genomic Risk Classifier to Predict Prostate Cancer-specific Mortality in Men with Adverse Pathologic Features.
Karnes RJ; Choeurng V; Ross AE; Schaeffer EM; Klein EA; Freedland SJ; Erho N; Yousefi K; Takhar M; Davicioni E; Cooperberg MR; Trock BJ
Eur Urol; 2018 Feb; 73(2):168-175. PubMed ID: 28400167
[TBL] [Abstract][Full Text] [Related]
14. Prospective study to define the clinical utility and benefit of Decipher testing in men following prostatectomy.
Marascio J; Spratt DE; Zhang J; Trabulsi EJ; Le T; Sedzorme WS; Beeler WH; Davicioni E; Dabbas B; Lin DW; Gore JL; Bloom M; Mann M; Mark JR; Calvaresi A; Godwin JL; McCue P; Hurwitz MD; Kelly WK; Lallas CD; Knudsen KE; Gomella LG; Dicker AP; Den RB
Prostate Cancer Prostatic Dis; 2020 Jun; 23(2):295-302. PubMed ID: 31719663
[TBL] [Abstract][Full Text] [Related]
15. Ability of a Genomic Classifier to Predict Metastasis and Prostate Cancer-specific Mortality after Radiation or Surgery based on Needle Biopsy Specimens.
Nguyen PL; Haddad Z; Ross AE; Martin NE; Deheshi S; Lam LLC; Chelliserry J; Tosoian JJ; Lotan TL; Spratt DE; Stoyanova RS; Punnen S; Ong K; Buerki C; Aranes M; Kolisnik T; Margrave J; Yousefi K; Choeurng V; Davicioni E; Trock BJ; Kane CJ; Pollack A; Davis JW; Feng FY; Klein EA
Eur Urol; 2017 Nov; 72(5):845-852. PubMed ID: 28528811
[TBL] [Abstract][Full Text] [Related]
16. Genomic Risk Predicts Molecular Imaging-detected Metastatic Nodal Disease in Prostate Cancer.
Xu MJ; Kornberg Z; Gadzinski AJ; Diao D; Cowan JE; Wu SY; Boreta L; Spratt DE; Behr SC; Nguyen HG; Cooperberg MR; Davicioni E; Roach M; Hope TA; Carroll PR; Feng FY
Eur Urol Oncol; 2019 Nov; 2(6):685-690. PubMed ID: 31411984
[TBL] [Abstract][Full Text] [Related]
17. Subpathologies and genomic classifier for treatment individualization of post-prostatectomy radiotherapy.
Ramotar M; Chua MLK; Truong H; Hosni A; Pintilie M; Davicioni E; Fleshner NE; Dicker AP; Bristow RG; He HH; van der Kwast T; Den RB; Berlin A
Urol Oncol; 2022 Jan; 40(1):5.e1-5.e13. PubMed ID: 34538726
[TBL] [Abstract][Full Text] [Related]
18. Clinical-genomic Characterization Unveils More Aggressive Disease Features in Elderly Prostate Cancer Patients with Low-grade Disease.
Goldberg H; Spratt D; Chandrasekar T; Klaassen Z; Wallis CJD; Santiago-Jimenez M; Fishbane N; Davicioni E; Noorani R; Ahmad AE; Herrera Cáceres JO; Alibhai S; Berlin A; Fleshner NE
Eur Urol Focus; 2021 Jul; 7(4):797-806. PubMed ID: 32156491
[TBL] [Abstract][Full Text] [Related]
19. Stromal Gene Expression is Predictive for Metastatic Primary Prostate Cancer.
Mo F; Lin D; Takhar M; Ramnarine VR; Dong X; Bell RH; Volik SV; Wang K; Xue H; Wang Y; Haegert A; Anderson S; Brahmbhatt S; Erho N; Wang X; Gout PW; Morris J; Karnes RJ; Den RB; Klein EA; Schaeffer EM; Ross A; Ren S; Sahinalp SC; Li Y; Xu X; Wang J; Wang J; Gleave ME; Davicioni E; Sun Y; Wang Y; Collins CC
Eur Urol; 2018 Apr; 73(4):524-532. PubMed ID: 28330676
[TBL] [Abstract][Full Text] [Related]
20. Health-related Quality of Life in Patients with Advanced Prostate Cancer: A Systematic Review.
Kretschmer A; Ploussard G; Heidegger I; Tsaur I; Borgmann H; Surcel C; Mathieu R; de Visschere P; Valerio M; van den Bergh RCN; Marra G; Thibault C; Ost P; Gandaglia G; Tilki D;
Eur Urol Focus; 2021 Jul; 7(4):742-751. PubMed ID: 32089495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
